Search

Your search keyword '"Ebrahim, Iftikhar O"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Ebrahim, Iftikhar O" Remove constraint Author: "Ebrahim, Iftikhar O"
19 results on '"Ebrahim, Iftikhar O"'

Search Results

1. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

2. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

3. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

4. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

6. Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG

8. PCSK9 Inhibitors: From Nature’s Lessons to Clinical Utility

9. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

10. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

11. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

12. PCSK9 Inhibitors : From Nature's Lessons to Clinical Utility

13. Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

14. Long-term safety and efficacy of alirocumab in South African patients with heterozygous familial hypercholesterolaemia: the ODYSSEY Open-Label Extension study

15. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

16. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

17. Real-world geographic variations in the use of cardiac implantable electronic devices--The PANORAMA 2 observational cohort study.

18. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

19. Changes in blood pressure after catheter-based renal denervation in South Africa.

Catalog

Books, media, physical & digital resources